MedPath

Cognitive stimulation therapy for elderly with cognitive and functional complaints: Brazilian adaptation and validatio

Not Applicable
Recruiting
Conditions
central nervous disease
Dementia in Alzheimer's disease
Vascular dementia
Unspecified dementia
Registration Number
RBR-3r6pc2
Lead Sponsor
Pontifícia Universidade Católica do Rio de Janeiro
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

Age over 60 years; Both genders; People diagnosed with dementia; Score between 10 and 24 on the Mini Mental State Exam; Be able to answer neuropsychological evaluation.

Exclusion Criteria

Age greater than 95 years. Mental retardation previously diagnosed according to ICD criteria 10.

Study & Design

Study Type
Intervention
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary endpoint is enhancement in cognition, as measured by the Cognitive Alzheimer's Disease Assessment (ADAS-Cog) scale. ADAS-Cog uses 11 tasks to measure cognitive domains, such as memory, praxis, and language. The differences in the responses found in the scales applied at the beginning and at the end of the study will be evaluated through statistical analysis using 2X2 ANOVA. Considering that this is a validation study, the analyzes will be exploratory. The scales will be applied within two weeks before the start of the study and within one week after the end of the study.
Secondary Outcome Measures
NameTimeMethod
Secondary outcomes include imporbvement in quality of life as measured by QoL-AD scale, imporvement in depressive symptoms as measured by Cornell Scale for Depression in Dementia (CSDD), imporvement in disease awareness as measured by ASPIDD scale and reduction in caregiver bruden as measured by Zarit Burden Scale (ZBI). The differences in the responses found in the scales applied at the beginning and at the end of the study will be evaluated. The scales will be applied within two weeks before the start of the study and within one week after the end of the study.
© Copyright 2025. All Rights Reserved by MedPath